Other Clinical Trial - Superior Venous Access, Midline vs Ultrasound IVs

Status Terminated

Clinical Trial Summary

Obtaining intravenous access (IVA) is the most common procedure performed in the emergency department (ED). Placement of IVA allows for blood work and delivery of intravenous fluids and medications. The implementation of ultrasound guided peripheral IVs (UGPIV) have allowed for ultrasound to be used to place an IV into patients with difficult vein access (DVA). An alternative device to place is a midline catheter (MC). The use of MCs against UGPIV has not been compared in a randomized study. Aim 1: To determine if UGPIVs have a higher failure rate than midline catheters within 72 hours of placement. Aim 2: To collect information to perform a direct cost analysis of UGPIV against that of the midline catheter. Aim 3: Assess patient satisfaction.

Clinical Trial Description

This is a randomized controlled trial to determine if the midline catheter is superior to the ultrasound guided IV with respect to survival at 72 hours. Aim 1: To determine if UGPIVs have a higher failure rate than midline catheters within 72 hours of placement. There are several reasons why UGPIVs may fail. UGPIVs are shorter than midline catheters, and shorter catheters may fail due to infiltration which can be a result of malposition as well as having the catheter pull out of the vessel. It is being hypothesized that by using a midline catheter with a guidewire for placement with additional catheter length placed into the vessel, midlines will be superior to UGP\Vs with regards to survival time of the catheter. The investigators will assess catheter survival daily until 72 hours (when UGPIV are recommended to be changed). The total lifetime of the midline catheters will be recorded. Aim 2: To perform a direct cost analysis of UGPIV against that of the midline catheter. This study will not be large enough to complete a robust cost effectiveness analysis to compare UGPIV to mid line catheters. As a part of this study the investigators will collect information including but not limited to: the number of catheters used for IVA attempts, time for placement of each device complications, and need for additional IVA during hospitalization. Aim 3: For patients that remain hospitalized at 72 hours a satisfaction survey will be administered to determine patient experience and preference for the type of vascular access that they receive. ;

Study Design

Related Conditions & MeSH terms

Ultrasound Therapy; Complications
Vascular Access Complication

Clinical Trial Details

NCT number	NCT03440944
Study type	Interventional
Source	Boston Medical Center
Contact
Status	Terminated
Phase	N/A
Start date	April 23, 2018
Completion date	January 25, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05778279` - Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies
Completed	`NCT04659395` - How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block	N/A
Recruiting	`NCT04438265` - Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
Recruiting	`NCT04952220` - Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee
Completed	`NCT04149041` - The Applications of Point-of-care Ultrasound in ED Unselected, Non-critical Patients
Completed	`NCT06000215` - Credibility of Ultrasound Detection of Female Genital Prolapse Mesh
Completed	`NCT04581616` - The Effect of Ultrasound-guided Erector Spinae Block and Intraoperative Intercostal Nerve Block on Postoperative Analgesia in Thoracic Surgery	N/A
Completed	`NCT05151432` - Effect of Pulsed Electromagnetic Field and Pulsed Ultrasound in Treating Knee Osteoarthritis	N/A
Completed	`NCT04674852` - Mayo Designed Soft Tissue Ultrasound-Detectable Marker	N/A
Recruiting	`NCT05627830` - Ultrasound Guided Versus Non-Guided Prolotherapy for Internal Derangement of Temporomandibular Joint.	N/A
Completed	`NCT04382430` - Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation	N/A
Completed	`NCT04917406` - Effect of Iontophoresis vs. Ultrasound and Iontophoresis in Plantar Fasciitis". Plantar Fasciitis"	N/A
Not yet recruiting	`NCT04862182` - Intrapartum Ultrasound in Predicting Mode of Delivery
Completed	`NCT03122119` - Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint	Phase 4
Completed	`NCT04753450` - Correlation of Muscle Ultrasound Measures (2D and 3D) With Biphotonic X-ray Absorptiometry in Oldest Old Patients.
Completed	`NCT03676699` - Lung Ultrasound in Detection of Extravascular Lung Water in Septic Patients.
Recruiting	`NCT03144895` - Arterial Catheterization by Ultrasound	N/A
Recruiting	`NCT05535816` - Accuracy of Ultrasound for Detecting Residual Fragments During RIRS	N/A
Recruiting	`NCT05769517` - PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES
Completed	`NCT05927285` - Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.